FDA Regulatory Expertise Navigate U.S. Market Entry with Confidence Comprehensive FDA regulatory support for foreign pharmaceutical manufacturers entering the U.S. market. FromANDA submissions to post-approval compliance. Request Regulatory Consultation Learn About Our Expertise ANDA Pathway Guidance Complete support for Abbreviated New Drug Application submissions to the FDA. AND A strategy development and planning Complete application preparation and review FDA correspondence and deficiency response Pre-submission feasibility assessment Regulatory Dossier Preparation Expert compilation of regulatory documentation meeting FDA standards. CTD/eCTD format preparation Chemistry, Manufacturing, and Controls(CMC) documentation Bioequivalence study documentation Quality assurance and regulatory compliance review U.S. Market Entry Strategy Strategic planning for successful entry into FDA-regulated markets. Competitive landscape analysis Regulatory pathway selection Timeline and resource planning Risk assessment and mitigation strategies Post-Approval Compliance Ongoing regulatory support to maintain FDA compliance after approval. Annual report preparation and submission Change control and supplement management FDA inspection readiness support Adverse event reporting and pharmacovigilance Initial Assessment Evaluate product viability and regulatory pathway Strategy Development Create comprehensive regulatory roadmap FDA Submission Submit application and manage FDA correspondence Dossier Preparation Compile and review all regulatory documentation Ongoing Support Post-approval compliance and maintenance why choose uppharmaceutical Partner with regulatory experts who understand both pharmaceutical science and FDA requirements. Pharmacist-Founded Perspective Understanding both the product and the pathway dual Expertise Dual Expertise Regulatory + Commercial Not just get you approved. Our team helps you succeed in the market Transparent Pricing Clear project scopes, no hidden consulting fees Regulatory Every generic medication undergoes comprehensive quality verification FDA cGMP Compliance: Manufacturing facilities meet 21 CFR Part 210 and 211 requirements Dissolution Testing: Bioavailability assessment ensures therapeutic equivalence to brand-name Stability Studies: Accelerated and long-term stability data confirms shelf life and storagerequirements Microbial Testing: Sterility testing and bioburden assessment for applicable formulations Certificate of Analysis (CoA): Complete analytical documentation provided for every product batch Active Pharmaceutical Ingredient (API) Verification: Independent testing confirms identity, purity,and potency of drug substances